Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Performance
Open
57.60Prev. Close
53.58Volume
0Total traded value
NAUpper Circuit
56.25Lower Circuit
50.91Fundamentals
| Market Cap | ₹80Cr |
| ROE | 0.48% |
| P/E Ratio(TTM) | 140.79 |
| EPS(TTM) | 0.39 |
| P/B Ratio | 2.99 |
| Dividend Yield | 0.00% |
| Industry P/E | 41.00 |
| Book Value | 18.37 |
| Debt to Equity | 0.00 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Novelix Pharmaceuticals
Trimurthi Limited operates in the pharmaceutical industry, engaged in the business of manufacturing, trading, and exporting various organic chemicals, pharmaceuticals, and drugs. Its core mission includes undertaking research to develop newer indigenous technologies and medicines for a wide range of therapeutic applications. In the 2023-24 financial year, the company achieved operational revenue of ₹422.38 Lakhs, a significant increase from the previous year.;
| Parent Organisation | Novelix Pharmaceuticals |
| Managing Director | Shri. Arun Bhangadia |
| BSE Symbol | 536565 |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 91.44 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.79 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.00 | ||
| Wockhardt | NA (0.00%) | -142.48 |